Merging Models of Hepatitis C Virus Pathogenesis

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Seminars in liver disease (Print)

• Publication date

  2005-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1055/s-2005-864784PMID 15732000
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Hepatic regeneration in humans with various liver disease as assessed by Ki-67 staining of formalin-fixed paraffin-embedded liver tissue.

  2008cited by this paper
• The liver biopsy in chronic hepatitis C: a view from the other side of the microscope.

  2005cited by this paper
• Hepatitis C virus particles and lipoprotein metabolism.

  2005cited by this paper
• Treatment of chronic hepatitis C in human immunodeficiency virus/hepatitis C virus-coinfected patients in the era of pegylated interferon and ribavirin.

  2005cited by this paper
• The nervous system and hepatitis C virus.

  2005cited by this paper
• Acute Hepatitis C: A Multifaceted Disease

  2005cited by this paper
• Management and Treatment of Injection Drug Users with Hepatitis C Virus (HCV) Infection and HCV/Human Immunodeficiency Virus Coinfection

  2005cited by this paper
• Donor age affects fibrosis progression and graft survival after liver transplantation for hepatitis C1

  2004cited by this paper
• Long-term outcome of liver transplants for chronic hepatitis C: a 10-year follow-up

  2004cited by this paper
• Prevention of critical telomere shortening by oestradiol in human normal hepatic cultured cells and carbon tetrachloride induced rat liver fibrosis

  2004cited by this paper
• Pathophysiology of hepatitis C virus infection and related liver disease.

  2004cited by this paper
• The epidemiology of chronic hepatitis C infection in survivors of childhood cancer: an update of the St Jude Children's Research Hospital hepatitis C seropositive cohort.

  2004cited by this paper
• FACTORS DIFFERENTIALLY CORRELATED WITH THE OUTCOME OF LIVER TRANSPLANTATION IN HCV+ AND HCV- RECIPIENTS

  2004cited by this paper
• Hepatitis C virus core and nonstructural proteins induce fibrogenic effects in hepatic stellate cells.

  2004cited by this paper
• Risks of a range of alcohol intake on hepatitis C‐related fibrosis

  2004cited by this paper
• Progression of hepatic fibrosis in patients with hepatitis C: a prospective repeat liver biopsy study

  2004cited by this paper
• Telomeres and telomerase: new targets for the treatment of liver cirrhosis and hepatocellular carcinoma.

  2004cited by this paper
• 91 Control of HIV viral load through highly active antiretroviral therapy (HAART) slows down liver fibrosis progression in HIV/HCV-coinfection and makes it the same as in HCV-monoinfection. The Puerto Rico-New York hepatitis C study group

  2004cited by this paper
• Hepatitis C and liver fibrosis

  2003cited by this paper
• Kupffer cell engulfment of apoptotic bodies stimulates death ligand and cytokine expression

  2003cited by this paper
• Associations of chemokine system polymorphisms with clinical outcomes and treatment responses of chronic hepatitis C.

  2003influential reference
• Mutation in collagen‐I that confers resistance to the action of collagenase results in failure of recovery from CCl4‐induced liver fibrosis, persistence of activated hepatic stellate cells, and diminished hepatocyte regeneration

  2003cited by this paper
• Replicative senescence of activated human hepatic stellate cells is accompanied by a pronounced inflammatory but less fibrogenic phenotype

  2003cited by this paper
• Telomerase reconstitution immortalizes human fetal hepatocytes without disrupting their differentiation potential.

  2003cited by this paper
• Telomere shortening impairs organ regeneration by inhibiting cell cycle re‐entry of a subpopulation of cells

  2003cited by this paper
• In overweight patients with chronic hepatitis C, circulating insulin is associated with hepatic fibrosis: implications for therapy.

  2003cited by this paper
• Impact of moderate alcohol consumption on histological activity and fibrosis in patients with chronic hepatitis C, and specific influence of steatosis: a prospective study

  2003cited by this paper
• Apoptotic Body Engulfment by a Human Stellate Cell Line Is Profibrogenic

  2003cited by this paper
• A novel MCP-1 gene polymorphism is associated with hepatic MCP-1 expression and severity of HCV-related liver disease.

  2003cited by this paper
• A pilot study of therapeutic vaccination with envelope protein E1 in 35 patients with chronic hepatitis C

  2003cited by this paper
• Contribution of donor age to the recent decrease in patient survival among HCV‐infected liver transplant recipients

  2002cited by this paper
• Hepatocyte telomere shortening and senescence are general markers of human liver cirrhosis.

  2002cited by this paper
• Polymorphisms of microsomal epoxide hydrolase gene and severity of HCV‐related liver disease

  2002cited by this paper
• Severity and correlates of liver disease in hepatitis C virus–infected injection drug users

  2002cited by this paper
• Effect of weight reduction on liver histology and biochemistry in patients with chronic hepatitis C

  2002cited by this paper
• Stimulation and proliferation of primary rat hepatic stellate cells by cytochrome P450 2E1–derived reactive oxygen species

  2002cited by this paper
• Factor V Leiden polymorphism and the rate of fibrosis development in chronic hepatitis C virus infection

  2002cited by this paper
• Alcohol use and hepatitis C

  2002cited by this paper
• Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C.

  2002cited by this paper
• Fibrosis and disease progression in hepatitis C

  2002cited by this paper
• Risk factors of hepatitis C virus‐related liver cirrhosis in young adults: Positive family history of liver disease and transporter associated with antigen processing 2 (TAP2) *0201 Allele

  2001cited by this paper
• Cigarette smoking and hepatic lesions in patients with chronic hepatitis C

  2001cited by this paper
• Hepatitis C virus infection.

  2001cited by this paper
• Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis c.

  2001cited by this paper
• Prevalence and clinical outcome of hepatitis C infection in children who underwent cardiac surgery before the implementation of blood-donor screening.

  2000cited by this paper
• c-Myb modulates transcription of the alpha-smooth muscle actin gene in activated hepatic stellate cells.

  2000cited by this paper
• Host genetic factors influence disease progression in chronic hepatitis C

  2000cited by this paper
• Low frequency of cirrhosis in a hepatitis C (genotype 1b) single‐source outbreak in germany: A 20‐year multicenter study

  2000cited by this paper
• Inhibition of experimental liver cirrhosis in mice by telomerase gene delivery.

  2000cited by this paper
• Assessment of Long‐Term Outcomes of Community‐Acquired Hepatitis C Infection in a Cohort With Sera Stored From 1971 to 1975

  2000cited by this paper
• Hydrogen peroxide: A link between acetaldehyde‐elicited α1(i) collagen gene up‐regulation and oxidative stress in mouse hepatic stellate cells

  2000cited by this paper
• Hepatocyte proliferative activity in human liver cirrhosis.

  1999cited by this paper
• Mammalian telomeres end in a large duplex loop.

  1999cited by this paper
• Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin. Irish Hepatology Research Group.

  1999cited by this paper
• Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin.

  1999cited by this paper
• Cytokines and Fibrogenesis

  1999cited by this paper
• Microarray analysis of replicative senescence.

  1999cited by this paper
• Prevalence and clinical outcome of hepatitis C infection in children who underwent cardiac surgery before the implementation of blood-donor screening.

  1999cited by this paper
• Cytokines induce NF-κB in activated but not in quiescent rat hepatic stellate cells.

  1998cited by this paper
• Extension of life-span by introduction of telomerase into normal human cells.

  1998cited by this paper
• Telomerase activation by hTRT in human normal fibroblasts and hepatocellular carcinomas

  1998cited by this paper
• Telomerase Catalytic Subunit Homologs from Fission Yeast and Human

  1997cited by this paper
• Telomere shortening and tumor formation by mouse cells lacking telomerase RNA.

  1997cited by this paper
• Hepatitis B and C in HIV-infected patients. Prevalence and prognostic value.

  1997cited by this paper
• Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups.

  1997influential reference
• hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization.

  1997cited by this paper
• Regulation of cyclin‐dependent kinase inhibitor p21WAF1/Cip1/Sdi1 gene expression in hepatic regeneration

  1997cited by this paper
• Posttranscriptional regulation of collagen alpha1(I) mRNA in hepatic stellate cells

  1997cited by this paper
• Mortality from liver cancer and liver disease in haemophilic men and boys in UK given blood products contaminated with hepatitis C. UK Haemophilia Centre Directors' Organisation.

  1997cited by this paper
• Telomerase catalytic subunit homologs from fission yeast and human.

  1997cited by this paper
• The end replication problem: More than one solution

  1997cited by this paper
• The long‐term pathological evolution of chronic hepatitis C

  1996cited by this paper
• Relationship between hepatocyte proliferative activity and liver functional reserve in human cirrhosis

  1996cited by this paper
• Histological features predictive of liver fibrosis in chronic hepatitis C infection.

  1996cited by this paper
• p53 expression in patients with cirrhosis with and without hepatocellular carcinoma

  1995influential reference
• Clinical outcomes after transfusion-associated hepatitis C.

  1995cited by this paper
• Sp1 binding activity increases in activated Ito cells

  1995cited by this paper
• Activation of hepatic stellate cells by TGF alpha and collagen type I is mediated by oxidative stress through c-myb expression.

  1995cited by this paper
• Hepatitis C infection in patients with primary hypogammaglobulinemia after treatment with contaminated immune globulin.

  1994cited by this paper
• Molecular and cell biology of replicative senescence.

  1994cited by this paper
• The two-stage mechanism controlling cellular senescence and immortalization.

  1992cited by this paper
• The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team.

  1992cited by this paper
• Structure and function of telomeres

  1991cited by this paper
• Telomeres shorten during ageing of human fibroblasts

  1990influential reference
• Structure and function of telomeres.

  1989cited by this paper
• A telomeric sequence in the RNA of Tetrahymena telomerase required for telomere repeat synthesis

  1989cited by this paper
• Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis.

  1989cited by this paper

• Serum albumin and white matter hyperintensities

  2024cites this paper
• Serum albumin and white matter hyperintensities

  2024cites this paper
• Extended Interferon-Alpha Therapy Accelerates Telomere Length Loss in Human Peripheral Blood T Lymphocytes

  2016cites this paper
• The Fundamental Role Played by Cell Cycle Proteins in Controlling Cell Proliferation in Chronic Hepatitis C Virus Infection.

  2016cites this paper
• LIVER BIOPSY IN THE EVALUATION OF THE IN LIVER FIBROSIS IN CHRONIC VIRAL HEPATITIS C CORINA BECA

  2015cites this paper
• Analysis of the intrahepatic ductular reaction and progenitor cell responses in hepatitis C virus recurrence after liver transplantation

  2014cites this paper
• Influence of antiviral therapy in the long‐term outcome of recurrent hepatitis C virus infection following liver transplantation

  2013cites this paper
• Telomere length and telomerase reverse transcriptase mRNA expression in patients with hepatitis C.

  2013cites this paper
• Clinical, biochemical and pathological profiles of 5464 Egyptian chronic hepatitis C-infected patients.

  2013cites this paper
• Hepatitis C virus-related hepatocellular carcinoma: An insight into molecular mechanisms and therapeutic strategies.

  2012cites this paper
• HEPATITIS - C VIRUS INFECTION, ENHANCING SILENT EPEDEMIC OF CORONARY ARTERY DISEASE

  2012cites this paper
• Cell defense systems against oxidative stress and endoplasmic reticulum stress: Mechanisms of regulation and the effect of hepatitis C virus

  2011cites this paper
• Telomere Length Dynamics in Human T Cells: A Dissertation

  2011cites this paper
• Recurrent Hepatitis C and Acute Allograft Rejection: Clinicopathologic Features With Emphasis on the Differential Diagnosis Between These Entities

  2011cites this paper
• Hepatitis C virus soluble E2 in combination with QuilA and CpG ODN induces neutralizing antibodies in mice.

  2011cites this paper
• Extended Interferon-Alpha Therapy Accelerates Telomere Length Loss in Human Peripheral Blood T Lymphocytes

  2011cites this paper
• [Cellular defense systems against oxidative and ER stresses: mechanisms of regulation and influence of hepatitis C virus].

  2011cites this paper
• Esteato-hepatite não alcoólica e esteatose em hepatite crônica pelo vírus C: prevalência e relações entre dados demográficos e clínico-laboratoriais com parâmetros histopatológicos

  2010cites this paper
• Perspectives on Fibrosis Progression in Hepatitis C: An à la Carte Approach to Risk Factors and Staging of Fibrosis

  2010cites this paper
• Evolution of hepatitis C virus in liver allografts

  2009cites this paper
• Autologous blood donor screening indicated a lower prevalence of viral hepatitis in East vs West Germany: epidemiological benefit from established health resources

  2009cites this paper
• Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver.

  2008cites this paper
• Correlation Between Liver Fibrosis and Inflammation in Patients Transplanted for HCV Liver Disease

  2008cites this paper
• Mechanisms of Disease: HCV-induced liver injury

  2007cites this paper
• Hepatitis C virus core protein increases mitochondrial ROS production by stimulation of Ca2+ uniporter activity

  2007cites this paper
• Progression to cirrhosis in hepatitis C patients: an age‐dependent process

  2007cites this paper
• The association between hepatitis C infection and prevalent cardiovascular disease among HIV-infected individuals

  2007cites this paper
• Toll-like receptor expression in chronic hepatitis C: Correlation with pro-inflammatory cytokine levels and liver injury

  2006cites this paper
• Biliary wound healing, ductular reactions, and IL-6/gp130 signaling in the development of liver disease.

  2006cites this paper
• Hepatitis C in 2006.

  2006cites this paper
• Hepatitis C disease progression: From 5 years to 50 years

  2006cites this paper
• Hepatitis C — identifying patients with progressive liver injury

  2006cites this paper
• Wound Healing in the Biliary Tree of Liver Allografts

  2006cites this paper
• An editor's look‐back

  2006cites this paper
• The hepatitis C virus alternate reading frame (ARF) and its family of novel products: the alternate reading frame protein/F-protein, the double-frameshift protein, and others.

  2005cites this paper
• The Liver Biopsy in Chronic Hepatitis C: A View from the Other Side of the Microscope

  2005cites this paper
• The Hepatitis C Virus Alternate Reading Frame (ARF) and Its Family of Novel Products: The Alternate Reading Frame Protein/F-Protein, the Double-Frameshift Protein, and Others

  2005cites this paper
• Hepatitis C virus infection in the elderly

  2005cites this paper
• The liver biopsy in chronic hepatitis C: a view from the other side of the microscope.

  2005cites this paper
• Early HCV‐associated stellate cell activation in aggressive recurrent HCV: What can liver allografts teach about HCV pathogenesis?

  2005cites this paper